Enanta Pharma (ENTA) Tops Q2 EPS by 8c

Enanta Pharma (NASDAQ: ENTA) reported Q2 EPS of $0.61, $0.08 better than the analyst estimate of $0.53. Revenue for the quarter came in at $44.05 million versus the consensus estimate of $40.77 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Lightpath Technologies (LPTH) Misses Q4 EPS by 5c
• Academy Sports and Outdoor (ASO) Tops Q2 EPS by 22c, Offers Guidance